54 related articles for article (PubMed ID: 3291763)
1. [Mechanism of action of antineoplastic agents in the DNA synthesis of tumor cells].
Nakamura T; Uchida M
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):1003-10. PubMed ID: 3291763
[TBL] [Abstract][Full Text] [Related]
2. [Pharmacodynamics and action mechanism of antitumor agents].
Nakamura T; Ueda T
Gan To Kagaku Ryoho; 1993 Sep; 20(12):1731-40. PubMed ID: 8379666
[TBL] [Abstract][Full Text] [Related]
3. DNA synthesis inhibition of nitroxide radicals on leukemia cells.
Liu LS; Zheng RL; Swartz HM; Zhang ZY; Wei LL
Sci China B; 1991 Sep; 34(9):1063-9. PubMed ID: 1821128
[TBL] [Abstract][Full Text] [Related]
4. Interactions of antitumor triazoloacridinones with DNA.
Koba M; Konopa J
Acta Biochim Pol; 2007; 54(2):297-306. PubMed ID: 17446935
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxicity of 2-ethenyl-2,3-dihydrophthalazine-1,4-diones in murine and human tumor cultured cells.
Hall IH; Covington DW; Wheaton JR; Izydore RA; Zhou X
Pharmazie; 2001 Feb; 56(2):168-74. PubMed ID: 11234348
[TBL] [Abstract][Full Text] [Related]
6. Quinolone action against human topoisomerase IIalpha: stimulation of enzyme-mediated double-stranded DNA cleavage.
Bromberg KD; Burgin AB; Osheroff N
Biochemistry; 2003 Apr; 42(12):3393-8. PubMed ID: 12653542
[TBL] [Abstract][Full Text] [Related]
7. Chinese hamster ovary cells resistant to the topoisomerase II catalytic inhibitor ICRF-159: a Tyr49Phe mutation confers high-level resistance to bisdioxopiperazines.
Sehested M; Wessel I; Jensen LH; Holm B; Oliveri RS; Kenwrick S; Creighton AM; Nitiss JL; Jensen PB
Cancer Res; 1998 Apr; 58(7):1460-8. PubMed ID: 9537249
[TBL] [Abstract][Full Text] [Related]
8. DNA repair, ADP-ribosylation and pyridine nucleotide metabolism as targets for cancer chemotherapy.
Berger NA; Berger SJ; Gerson SL
Anticancer Drug Des; 1987 Oct; 2(2):203-9. PubMed ID: 3329525
[TBL] [Abstract][Full Text] [Related]
9. Induction of topoisomerase I-mediated DNA cleavage by a new indolocarbazole, ED-110.
Yoshinari T; Yamada A; Uemura D; Nomura K; Arakawa H; Kojiri K; Yoshida E; Suda H; Okura A
Cancer Res; 1993 Feb; 53(3):490-4. PubMed ID: 8381047
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of action of DNA topoisomerase inhibitors.
Binaschi M; Zunino F; Capranico G
Stem Cells; 1995 Jul; 13(4):369-79. PubMed ID: 7549896
[TBL] [Abstract][Full Text] [Related]
11. The cardio-protecting agent and topoisomerase II catalytic inhibitor sobuzoxane enhances doxorubicin-DNA adduct mediated cytotoxicity.
Swift LP; Cutts SM; Nudelman A; Levovich I; Rephaeli A; Phillips DR
Cancer Chemother Pharmacol; 2008 Apr; 61(5):739-49. PubMed ID: 17594094
[TBL] [Abstract][Full Text] [Related]
12. Dual topoisomerase I and II inhibition by intoplicine (RP-60475), a new antitumor agent in early clinical trials.
Poddevin B; Riou JF; Lavelle F; Pommier Y
Mol Pharmacol; 1993 Oct; 44(4):767-74. PubMed ID: 8232227
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxicity of ribo-and arabinoside boron nucleosides in tissue culture cells.
Sood A; Spielvogel BF; Powell WJ; Bastow KF; Miller MC; Hall IH
Anticancer Res; 1994; 14(4A):1483-8. PubMed ID: 7979174
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of DNA replication by tirapazamine.
Peters KB; Wang H; Brown JM; Iliakis G
Cancer Res; 2001 Jul; 61(14):5425-31. PubMed ID: 11454687
[TBL] [Abstract][Full Text] [Related]
15. NK314, a novel topoisomerase II inhibitor, induces rapid DNA double-strand breaks and exhibits superior antitumor effects against tumors resistant to other topoisomerase II inhibitors.
Onda T; Toyoda E; Miyazaki O; Seno C; Kagaya S; Okamoto K; Nishikawa K
Cancer Lett; 2008 Jan; 259(1):99-110. PubMed ID: 17998154
[TBL] [Abstract][Full Text] [Related]
16. IP6-induced growth inhibition and differentiation of HT-29 human colon cancer cells: involvement of intracellular inositol phosphates.
Yang GY; Shamsuddin AM
Anticancer Res; 1995; 15(6B):2479-87. PubMed ID: 8669811
[TBL] [Abstract][Full Text] [Related]
17. The cytotoxic action of 1,3,5-triazabicyclo[3.1.0]hexane-2,4-diones and 1,3,5-triazine-4,6-(1 H,5 H)-diones in murine and human tumor cells.
Hall IH; Taylor K; Izydore RA; Coleman DE; Mitchell JA; Cummings R
Pharmazie; 1998 Jun; 53(6):398-405. PubMed ID: 9675770
[TBL] [Abstract][Full Text] [Related]
18. Boron substituted deoxyribonucleosides as cytotoxic agents.
Hall IH; Elkins A; Sood A; Tomasz J; SpielVogel BF
Anticancer Res; 1996; 16(6B):3709-14. PubMed ID: 9042245
[TBL] [Abstract][Full Text] [Related]
19. [Inhibitory effects of genistein on the synthesis of DNA and the protein expression of cyclin D1 in human gastric carcinoma cell-line].
Song D; Liu Y; Wang X; Yang Y
Wei Sheng Yan Jiu; 2002 Apr; 31(2):106-8. PubMed ID: 12561543
[TBL] [Abstract][Full Text] [Related]
20. Correlation of cytotoxicity and protein-associated DNA strand breaks for 2-(arylmethylamino)-1,3-propanediols.
Dorr RT; Bellamy W; Liddil JD; Baker A; Bair KW
Anticancer Drug Des; 1998 Oct; 13(7):825-35. PubMed ID: 9807165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
